130 related articles for article (PubMed ID: 12043313)
1. [Levels of hyaluronic acid in chronic viral C hepatitis with relationship to liver steatosis].
Grzeszczuk A; Łapiński TW; Panasiuk A
Wiad Lek; 2002; 55(1-2):35-41. PubMed ID: 12043313
[TBL] [Abstract][Full Text] [Related]
2. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
[TBL] [Abstract][Full Text] [Related]
4. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
[TBL] [Abstract][Full Text] [Related]
6. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
[TBL] [Abstract][Full Text] [Related]
7. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
8. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
9. Serum hyaluronic acid as a marker of hepatic fibrosis.
Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
[TBL] [Abstract][Full Text] [Related]
10. Assessment of liver fibrosis development in chronic hepatitis B patients by serum hyaluronic acid and laminin levels.
Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D
Acta Clin Croat; 2010 Sep; 49(3):257-65. PubMed ID: 21462814
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive clinical assessment improves the accuracy of predicting cirrhosis in chronic hepatitis C.
Gordon A; Bailey MJ; Gibson PR; Roberts SK
J Gastroenterol Hepatol; 2005 Jun; 20(6):825-32. PubMed ID: 15946128
[TBL] [Abstract][Full Text] [Related]
13. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation in patients with chronic hepatitis C.
Fusegawa H; Shiraishi K; Ogasawara F; Shimizu M; Haruki Y; Miyachi H; Matsuzaki S; Ando Y
Tokai J Exp Clin Med; 2002 Dec; 27(4):101-6. PubMed ID: 12713014
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis in Iranian patients with chronic hepatitis C.
Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
[TBL] [Abstract][Full Text] [Related]
18. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
[TBL] [Abstract][Full Text] [Related]
19. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
[TBL] [Abstract][Full Text] [Related]
20. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
